PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'COVID Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy. Electronic address: dgenerali@units.it.\', \'Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.\', \'COVID Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy.\', \'Haemostasis and Thrombosis Center, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy.\', \'Radiology Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy.\', \'Pharmacy Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy.\', \'Department of Management, University of Turin, Turin, Italy; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Milan, Italy.\', \'Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.\', \'Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(20)32597-210.1016/j.ijid.2020.12.073
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33385581
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all